Payment overview · 2025
General Payments
$171.11
3 reported records · 3 companies
Healthcare provider profile · identity verified
Juan Cancio, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HIALEAH, FL · NPI 1366463796
Verified facts
What the public records show
CMS Open Payments records show Juan Cancio, M.D. received $171.11 in general payments during 2025 across 3 reported records.
BridgeBio Pharma, Inc. accounted for 82.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Unresolved — no canonical attribution shown | $140.29 | 82.0% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.67 | 9.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.15 | 8.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $171.11 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Attruby Normalized: attruby |
Drug | BridgeBio Pharma, Inc. | $140.29 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $15.67 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.67 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 403 | 98 |
| Metoprolol Succinate | Metoprolol Succinate | 346 | 87 |
| Losartan Potassium | Losartan Potassium | 304 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 281 | 60 |
| Gabapentin | Gabapentin | 274 | 60 |
| Eliquis | Apixaban | 253 | 45 |
| Donepezil Hcl | Donepezil Hcl | 244 | 40 |
| Famotidine | Famotidine | 214 | 48 |
| Omeprazole | Omeprazole | 207 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 206 | 49 |
| Alprazolam | Alprazolam | 197 | 38 |
| Amlodipine Besylate | Amlodipine Besylate | 197 | 47 |
| Quetiapine Fumarate | Quetiapine Fumarate | 185 | 36 |
| Memantine Hcl | Memantine Hcl | 176 | 25 |
| Mirtazapine | Mirtazapine | 174 | 35 |
| Simvastatin | Simvastatin | 167 | 28 |
| Trazodone Hcl | Trazodone Hcl | 165 | 36 |
| Metformin Hcl | Metformin Hcl | 156 | 40 |
| Temazepam | Temazepam | 153 | 31 |
| Metformin Hcl Er | Metformin Hcl | 135 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 130 | 27 |
| Lisinopril | Lisinopril | 123 | 27 |
| Glimepiride | Glimepiride | 118 | 24 |
| Furosemide | Furosemide | 116 | 39 |
| Montelukast Sodium | Montelukast Sodium | 114 | 29 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 108 | 32 |
| Diclofenac Sodium | Diclofenac Sodium | 105 | 27 |
| Alendronate Sodium | Alendronate Sodium | 103 | 34 |
| Chlorthalidone | Chlorthalidone | 103 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 99 | 21 |
| Doxazosin Mesylate | Doxazosin Mesylate | 96 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 30 |
| Baclofen | Baclofen | 84 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 80 | 50 |
| Atenolol | Atenolol | 79 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 77 | 25 |
| Carvedilol | Carvedilol | 76 | 19 |
| Sucralfate | Sucralfate | 69 | 12 |
| Tramadol Hcl | Tramadol Hcl | 69 | 22 |
| Clonazepam | Clonazepam | 68 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 68 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 68 | 11 |
| Ssd | Silver Sulfadiazine | 68 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 67 | 19 |
| Latanoprost | Latanoprost | 65 | 15 |
| Sertraline Hcl | Sertraline Hcl | 65 | 19 |
| Azithromycin | Azithromycin | 64 | 43 |
| Potassium Chloride | Potassium Chloride | 64 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 61 | 18 |
| Memantine Hcl Er | Memantine Hcl | 59 | suppressed |
| Allopurinol | Allopurinol | 58 | 17 |
| Buspirone Hcl | Buspirone Hcl | 58 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 58 | suppressed |
| Folic Acid | Folic Acid | 58 | 19 |
| Valsartan | Valsartan | 55 | 14 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 55 | 12 |
| Prednisone | Prednisone | 53 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 53 | 12 |
| Ibuprofen | Ibuprofen | 51 | 18 |
| Levofloxacin | Levofloxacin | 50 | 46 |
| Risperidone | Risperidone | 50 | suppressed |
| Pregabalin | Pregabalin | 47 | suppressed |
| Entresto | Sacubitril/Valsartan | 46 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 15 |
| Meloxicam | Meloxicam | 45 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 44 | 11 |
| Mupirocin | Mupirocin | 42 | 15 |
| Silver Sulfadiazine | Silver Sulfadiazine | 42 | 12 |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Finasteride | Finasteride | 41 | 11 |
| Glipizide | Glipizide | 40 | suppressed |
| Lactulose | Lactulose | 40 | 13 |
| Nitroglycerin | Nitroglycerin | 40 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 39 | suppressed |
| Digoxin | Digoxin | 39 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 38 | 12 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 37 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 36 | suppressed |
| Nifedipine Er | Nifedipine | 35 | suppressed |
| Primidone | Primidone | 34 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 24 |
| Methenamine Hippurate | Methenamine Hippurate | 31 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 30 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | 11 |
| Lorazepam | Lorazepam | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Cefdinir | Cefdinir | 26 | 22 |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 22 | suppressed |
| Jardiance | Empagliflozin | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 21 | 12 |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Enulose | Lactulose | 17 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 11 |
| Novolog | Insulin Aspart | 15 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Imipramine Pamoate | Imipramine Pamoate | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Leflunomide | Leflunomide | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Spironolactone | Spironolactone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $171.11 · 3 records | BridgeBio Pharma, Inc. | Attruby, Cologuard Collection Kit, OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error